This metabolic brain boost revives memory in Alzheimer's miceAn experimental cancer drug has shown promise in re-energizing the brains of Alzheimer's mice, indicating potential new treatment methods.
Amgen plows ahead with costly, highly toxic cancer dosing despite FDA challengeFDA initiative Project Optimus aims to reduce toxicity of cancer drugs by pinpointing the right dosage before reaching patients.
Most Cancer Drugs Granted Accelerated FDA Approval May Not WorkMost cancer drugs granted accelerated approval do not demonstrate benefits within five years.FDA's accelerated approval program allows early access to promising drugs for fatal diseases, but with the tradeoff of potential unproven effectiveness.
Amgen plows ahead with costly, highly toxic cancer dosing despite FDA challengeFDA initiative Project Optimus aims to reduce toxicity of cancer drugs by pinpointing the right dosage before reaching patients.
Most Cancer Drugs Granted Accelerated FDA Approval May Not WorkMost cancer drugs granted accelerated approval do not demonstrate benefits within five years.FDA's accelerated approval program allows early access to promising drugs for fatal diseases, but with the tradeoff of potential unproven effectiveness.
Abandoning randomized controlled trials won't help cancer treatmentRandomized controlled trials (RCTs) should be phased out for cancer drugs, according to an Outlook article.
Gut microbiome discovery provides roadmap for life-saving cancer therapiesGut bacteria balance influences response to cancer drugs.